|
|
| Thérapies > Etude de marché sectorielle |
|
|
|
|
€ 955,00 |
Editeur
: |
Business Insight |
Langue
: |
Anglais |
Date de publication : |
Septembre 2000 |
Taille du document : |
128 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 179 pages | Juin 2006 | Anglais
|
|
|
| Main
focus: |
cancer,lung cancer,breast cancer,oncology,...,...
|
| Research
focus: |
demand analysis,market outlook, |
| Geographic
focus: |
new zealand,united kingdom,canada,usa,australia,... |
| |
|
|
|
|
| 92 pages | Février 2008 | Anglais
|
|
|
| Main
focus: |
cancer,oncology,lymphoma,breast cancer,...,...
|
| Research
focus: |
market size and estimates,market definition, |
| Geographic
focus: |
usa,france,germany,united kingdom,switzerland,... |
| |
|
|
|
|
| 82 pages | Mai 2003 | Anglais
|
|
|
| Main
focus: |
cancer,breast cancer,lung cancer,lymphoma,...,...
|
| Research
focus: |
demand analysis,market definition,market outlook, |
| Geographic
focus: |
united kingdom,ireland,usa,india,france,canada,... |
| |
|
|
|
|
| 76 pages | Janvier 2002 | Anglais
|
|
|
| Main
focus: |
cancer,breast cancer,prostate cancer,lung cancer,...,...
|
| Research
focus: |
market definition,market outlook |
| Geographic
focus: |
canada,france,australia |
| |
|
|
|
|
| 58 pages | Mars 2006 | Anglais
|
|
|
| Main
focus: |
cancer,prostate cancer,oncology,cancer treatment,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
canada,usa,france,united kingdom,japan,germany,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Stakeholder Insight: Pancreatic Cancer - Gold Standard Gemcitabine Waiting to be Challenged
259 pages | Décembre 2004 |
IntroductionPancreatic adenocarcinoma is the fifth leading cancer-related cause of death and is thus a major health issue in the developed world.
Its aggressive nature and resistance to conventiona |
12 160,00 €
|
| |
| |
Neuroprotection in Stroke - Protecting the Brain Sells
54 pages | Janvier 2005 |
IntroductionStroke is one of the leading causes of death and adult disability worldwide.
Nevertheless, acute treatments for stroke are severely limited.
Neuroprotective drugs, which boast the ab |
1 520,00 €
|
| |
| |
Market Leaders in Oncology 2004 - Roche and Genentech Continue to Blaze a Trail
71 pages | Janvier 2005 |
IntroductionRoche continues to lead the oncology sector, recording oncology sales of $5,719m in 2003.
This sector dominance is predicted to continue between 2004 and 2010, due to Roche's ability to |
3 040,00 €
|
| |
| |
Stakeholder Opinions: Chronic Leukemias - Curative Intent Raises the Bar
174 pages | Octobre 2005 |
IntroductionRecognizing that prolonging disease-free survival in chronic leukemia relies on the eradication of minimal residual disease has raised the bar for developers of novel pharmacotherapy.
I |
3 230,00 €
|
| |
| |
MarketWatch: Cancer
28 pages | Novembre 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the |
170,00 €
|
| |
| |
MarketWatch: CNS
27 pages | Mai 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
MarketWatch: Cancer
27 pages | Mai 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the |
160,00 €
|
| |
| |
Pipeline Insight: Hematological malignancies - Targeted treatments and immunotherapy infuse new blood
219 pages | Avril 2005 |
IntroductionGiven an enhanced understanding of the biological basis for oncogenesis and the benefit of immunotherapy approaches such as Genentech/Roche's Rituxan, it is no surprise that targeted treat |
9 120,00 €
|
| |
| |
MarketWatch: CNS
30 pages | Avril 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
Pipeline Insight: Cancer Vaccines and Cell Therapies - Technical Know How Needs Translation Into Clinical and Commercial Rewards
203 pages | Avril 2005 |
IntroductionUnmet need across the cancer market is high, with most therapies conferring low levels of specificity and high toxicity.
Development of cancer vaccines may be the holy grail, with the p |
9 120,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
Driven by the cytotoxic, adjunct and innovative drug classes, the cancer market
grew by 16% in 1999 to a global value of almost $19bn, and is now poised on
the verge of a period of significant expansion.
A combination of an increasing disease burden and better understanding of cancer
within both the medical community and the public at large has created a growing
opportunity for cancer therapeutics.
In response to this opportunity, the biopharmaceutical industry has invested
heavily in R&D which has seen a number of innovative therapies reaching, or
about to reach the market, fuelling further growth.
This report is a single source of all the key epidemiological, market, licensing
and R&D data to provide you with a detailed analysis of the current and future
dynamics within the cancer market.
We have the answers for you:
• Across the cancer market, which products have recorded significant revenues
in recent years?
• How are competing companies positioning themselves within this expanding market?
• In which areas are companies currently focusing their R&D resources?
• Which innovative therapies will reach the market within the next five years
and what will be their impact?
• What are the optimum components of a successful cancer franchise?
• To what extent will generic competition erode market share of branded products?
• What are the major unmet needs in the treatment of cancers and how can they
be targeted?
• To what extent can strategic alliances lessen the financial risk associated
with R&D investment?
|
|
Chapter 1: Patient potential
Chapter 2: Market analysis & forecasts
Chapter 3: Unmet need
Chapter 4: New market opportunities
Chapter 5: Appendices
|
|
|
PPLSEN
|
|
|
|
|
